RCA Regional Office E-learning

e-Learning

Oncology

Non-Hodgkin’s lymphoma

First Seminar of the Korean Society of Blood transfusion's Immunology and Hematology Committee in 2019
Lecturer Narjess Ayati MD, IBNM, FEBNM, ABNC, FANMB
Objectives Overall objectives
On successful completion of this activity, participant should have an overview of Non-Hodgkin’s lymphoma (NHL), and the role of FDG-PET/CT in patient management.

Specific objectives
Following completion of this activity, the participant will achieve a brief knowledge about Non-Hodgkin’s lymphoma including:
Epidemiology & Risk factors
Prognosis and prognostic factors
Clinical presentation
Classification
Initial diagnosis & staging
Patient management
Role of FDG PET/CT in NHL
Response assessment criteria (including Deauville 5-point scoring system)
Video 16min

Subtitle

Lecturer

Narjess Ayati, MD, IBNM, FEBNM, ABNC, FANMB
Department of Molecular Imaging and Therapy
Austin Health, Melbourne, Australia
E-mail:n_ayati@yahoo.com
Sze Ting LEE, MBBS, PhD, FRACP, FAANMS, Associate Professor
Department of Molecular Imaging & Therapy,
Austin Health, Victoria, Australia
E-mail:sze.ting.lee@bigpond.com